Janice A. Nagy

18.7k total citations · 5 hit papers
132 papers, 14.5k citations indexed

About

Janice A. Nagy is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Janice A. Nagy has authored 132 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 28 papers in Physiology and 27 papers in Cancer Research. Recurrent topics in Janice A. Nagy's work include Angiogenesis and VEGF in Cancer (49 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Muscle activation and electromyography studies (21 papers). Janice A. Nagy is often cited by papers focused on Angiogenesis and VEGF in Cancer (49 papers), Cancer, Hypoxia, and Metabolism (23 papers) and Muscle activation and electromyography studies (21 papers). Janice A. Nagy collaborates with scholars based in United States, Israel and Netherlands. Janice A. Nagy's co-authors include Harold F. Dvorak, Ann M. Dvořàk, Lawrence F. Brown, Donald R. Senger, Livingston Van De Water, E J Manseau, Dian Feng, Timothy A. Springer, Francisco Sánchez‐Madrid and E. Robbins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Janice A. Nagy

128 papers receiving 14.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.

1983 779 citations Francisco Sánchez‐Madrid, Janice A. Nagy et al. The Journal of Experimental Medicine profile →
Vascular permeability factor (VPF, VEGF) in tumor biology

1993 716 citations Donald R. Senger, Livingston Van De Water et al. profile →
Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis

1999 618 citations Harold F. Dvorak, Janice A. Nagy et al. profile →
Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

1988 560 citations Harold F. Dvorak, Janice A. Nagy et al. profile →
The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.

1983 483 citations Francisco Sánchez‐Madrid, E. Robbins et al. profile →

Peers

Countries citing papers authored by Janice A. Nagy

Since Specialization

Citations

This map shows the geographic impact of Janice A. Nagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice A. Nagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice A. Nagy more than expected).

Fields of papers citing papers by Janice A. Nagy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice A. Nagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice A. Nagy. The network helps show where Janice A. Nagy may publish in the future.

Co-authorship network of co-authors of Janice A. Nagy

This figure shows the co-authorship network connecting the top 25 collaborators of Janice A. Nagy. A scholar is included among the top collaborators of Janice A. Nagy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice A. Nagy. Janice A. Nagy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Surface Electrical Impedance Myography Detects Skeletal Muscle Atrophy in Aged Wildtype Zebrafish and Aged gpr27 Knockout Zebrafish 2023 ·Biomedicines ·Seward B. Rutkove, Zsu‐Zsu Chen, (unknown), (unknown), (unknown), Janice A. Nagy, Anjali K. Nath	7
2	Approximate complex electrical potential distribution in the monodomain model with unequal conductivity and relative permittivity anisotropy ratios 2019 ·Physiological Measurement ·(unknown), (unknown), Janice A. Nagy, Seward B. Rutkove, Benjamin Sanchez	7
3	Moderation of Calpain Activity Promotes Neovascular Integration and Lumen Formation during VEGF-Induced Pathological Angiogenesis 2010 ·PLoS ONE ·Mien Van Hoang, Janice A. Nagy, Joan E.B. Fox, Donald R. Senger	29
4	VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine Protease Inhibitor Balance in Venules, Causing Basement Membrane Degradation and Mother Vessel Formation 2009 ·Cancer Research ·(unknown), Keizo Kanasaki, Vasilena Gocheva, Galia Blum, Jay Harper, Marsha A. Moses, (unknown), Janice A. Nagy, Johanna A. Joyce, Matthew Bogyo, Raghu Kalluri, Harold F. Dvorak	97
5	The L6 Protein TM4SF1 Is Critical for Endothelial Cell Function and Tumor Angiogenesis 2009 ·Cancer Research ·Shou‐Ching Shih, (unknown), Dan Li, Guanmei Liu, Lay‐Hong Ang, Janice A. Nagy, Lawrence F. Brown, Harold F. Dvorak	73
6	Chapter 3 The Adenoviral Vector Angiogenesis/Lymphangiogenesis Assay 2008 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Janice A. Nagy, Shou‐Ching Shih, (unknown), Ann M. Dvořàk, Harold F. Dvorak	17
7	Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting 2007 ·The Journal of Experimental Medicine ·Maria Wirzenius, Tuomas Tammela, Marko Uutela, Yulong He, Teresa Odorisio, Giovanna Zambruno, Janice A. Nagy, Harold F. Dvorak, Seppo Ylä‐Herttuala, Masabumi Shibuya, Kari Alitalo	156
8	Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity 2006 ·The Journal of Experimental Medicine ·Huiyan Zeng, LiuLiang Qin, Dezheng Zhao, Xiaolian Tan, E J Manseau, Mien Van Hoang, Donald R. Senger, Lawrence F. Brown, Janice A. Nagy, Harold F. Dvorak	133
9	Down Syndrome Candidate Region 1 Isoform 1 Mediates Angiogenesis through the Calcineurin-NFAT Pathway 2006 ·Molecular Cancer Research ·LiuLiang Qin, Dezheng Zhao, Xin Liu, Janice A. Nagy, Mien Van Hoang, Lawrence F. Brown, Harold F. Dvorak, Huiyan Zeng	65
10	Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. 2006 ·Cancer Research ·Thuy L. Phung, Carole Perruzzi, Rita A. Monahan-Earley, Janice A. Nagy, David M. Briscoe, Kenneth Walsh, William C. Sessa, Ann M. Dvořàk, Harold F. Dvorak, Laura E. Benjamin	6
11	Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin 2006 ·Cancer Cell ·Thuy L. Phung, Keren Ziv, Donnette Dabydeen, (unknown), Marcela Riveros, Carole Perruzzi, Jingfang Sun, Rita A. Monahan-Earley, Ichiro Shiojima, Janice A. Nagy, Michelle I. Lin, Kenneth Walsh, Ann M. Dvořàk, David M. Briscoe, Michal Neeman, William C. Sessa, Harold F. Dvorak, Laura E. Benjamin	356
12	Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis 2002 ·The Journal of Experimental Medicine ·Janice A. Nagy, Eliza Vasile, Dian Feng, Christian Sundberg, Lawrence F. Brown, Michael Detmar, Joel Lawitts, Laura E. Benjamin, Xiaolian Tan, E J Manseau, Ann M. Dvořàk, Harold F. Dvorak	436
13	Platelets Exit Venules by a Transcellular Pathway at Sites of F–Met Peptide–Induced Acute Inflammation in Guinea Pigs 1998 ·International Archives of Allergy and Immunology ·Dian Feng, Janice A. Nagy, Kathryn Pyne, Harold F. Dvorak, Ann M. Dvořàk	33
14	Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine 1997 ·Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions ·Lawrence F. Brown, Michael Detmar, Kevin P. Claffey, Janice A. Nagy, D. Feng, Ann M. Dvořàk, Harold F. Dvorak	401
15	Keratinocyte-Derived Vascular Permeability Factor (Vascular Endothelial Growth Factor) Is a Potent Mitogen for Dermal Microvascular Endothelial Cells 1995 ·Journal of Investigative Dermatology ·(unknown), Kiang-Teck Yeo, Janice A. Nagy, Livingston Van De Water, Lawrence F. Brown, Brygida Berse, Brett M. Elicker, Stephen Ledbetter, Harold F. Dvorak	213
16	Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. 1994 ·Journal of Clinical Investigation ·Satoru Harada, Janice A. Nagy, Kathleen A. Sullivan, Kenneth A. Thomas, Naoto Endo, Gideon A. Rodan, Sevgi B. Rodan	334
17	Lymphatic and Nonlymphatic Pathways of Peritoneal Absorption in Mice: Physiology versus Pathology 1992 ·Blood Purification ·Janice A. Nagy	26
18	Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. 1991 ·The Journal of Experimental Medicine ·Harold F. Dvorak, Tracy M. Sioussat, Lawrence F. Brown, Brygida Berse, Janice A. Nagy, Ana Sotrel, E J Manseau, Livingston Van De Water, Donald R. Senger	419
19	Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition 1989 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Janice A. Nagy, Lawrence F. Brown, Donald R. Senger, Naomi Lanir, Livingston Van De Water, Ann M. Dvořàk, Harold F. Dvorak	335
20	A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule. breakdown → 1983 ·The Journal of Experimental Medicine ·Francisco Sánchez‐Madrid, Janice A. Nagy, E. Robbins, Paul Simon, Timothy A. Springer	779

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact